Clinical Trial Update: Growth Hormone in Poor Responders to IVF Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating growth hormone in poor responders undergoing IVF has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Pacific Centre for Reproductive Medicine | Conditions: Infertility | Phase 2, Phase 3 | Status: TERMINATED